• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lobe Sciences Ltd (CSE:LOBE)

0.1150 +0.0150 (+15.00%)
Streaming Delayed Price Updated: 12:45 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 21,435
Open 0.1150
Bid (Size) 0.1050 (2,000)
Ask (Size) 0.1150 (36,000)
Prev. Close 0.1000
Today's Range 0.1150 - 0.1150
52wk Range 0.0300 - 0.1800
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Lobe Sciences Announces Proposed Shares for Debt Transaction
June 01, 2026
Via ACCESS Newswire
News headline image
Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
May 06, 2026
Via ACCESS Newswire

Performance

YTD
+130.0%
+130.0%
1 Month
-17.9%
-17.9%
3 Month
+91.7%
+91.7%
6 Month
+187.5%
+187.5%
1 Year
+283.3%
+283.3%

More News

Read More
News headline image
Lobe Sciences Reports Second Quarter 2026 Results and Highlights Continued Operational Progress
May 06, 2026
Via ACCESS Newswire
News headline image
Lobe Sciences Ltd. Comments on White House Executive Order Supporting Drug Development for Neurological and Mental Health Disorders
April 23, 2026
Via ACCESS Newswire
News headline image
Lobe Sciences Ltd. Engages Massive Intelligence Pty Ltd for Investor Relations and Corporate Communications Services
April 21, 2026
Via ACCESS Newswire
News headline image
Lobe Sciences Ltd. Announces Non-Brokered Private Placement
April 10, 2026
Via ACCESS Newswire
News headline image
Lobe Sciences Ltd. Reports Improved Financial Position and Strategic Update
March 25, 2026
Via ACCESS Newswire
News headline image
Lobe Sciences Announces Appointment of Mr. Mirza Rahimani, CPA, CA as Chief Financial Officer
March 09, 2026
Via ACCESS Newswire
News headline image
Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences
March 05, 2026
Via ACCESS Newswire
News headline image
Lobe Sciences Reports First Quarter 2026 Results and Highlights
February 03, 2026
Via ACCESS Newswire
News headline image
Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
January 13, 2026
Via ACCESS Newswire
News headline image
Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy
January 08, 2026
Via ACCESS Newswire
News headline image
Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition
January 06, 2026
Via ACCESS Newswire
News headline image
Lobe Sciences Completes Debt Settlement to Improve Balance Sheet
October 23, 2025
Via ACCESS Newswire
News headline image
Lobe Sciences Improves Balance Sheet
October 09, 2025
Via ACCESS Newswire
News headline image
Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
September 09, 2025
Via ACCESS Newswire
News headline image
Lobe Sciences Announces the Appointment of Marco Mastrodonato to its Board of Directors
September 08, 2025
Via ACCESS Newswire
News headline image
Lobe Sciences Announces the Closing of the Previously Announced Private Placement
August 14, 2025
Via ACCESS Newswire
News headline image
Lobe Sciences Ltd. Engages ArcStone Securities for Strategic Capital Markets Advisory
July 29, 2025
Via ACCESS Newswire
News headline image
Lobe Sciences Ltd. Announces Debt Settlement
July 16, 2025
Via ACCESS Newswire
News headline image
Lobe Sciences Announces Validation of European Unitary Patent for DHA-Based Composition for Sickle Cell Disease
July 08, 2025
Via ACCESS Newswire
News headline image
Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals
June 17, 2025
Via ACCESS Newswire
News headline image
Lobe Sciences Appoints Mr. Yong Yao as Chief Financial Officer to Support Strategic Growth
June 03, 2025
Via ACCESS Newswire
News headline image
Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM)
April 14, 2025
Via ACCESS Newswire
News headline image
Lobe Sciences Provides Corporate Update
April 04, 2025
Via ACCESS Newswire

Frequently Asked Questions

Is Lobe Sciences Ltd publicly traded?
Yes, Lobe Sciences Ltd is publicly traded.
What exchange does Lobe Sciences Ltd trade on?
Lobe Sciences Ltd trades on the Canadian Securities Exchange
What is the ticker symbol for Lobe Sciences Ltd?
The ticker symbol for Lobe Sciences Ltd is LOBE on the Canadian Securities Exchange
What is the current price of Lobe Sciences Ltd?
The current price of Lobe Sciences Ltd is 0.1150
When was Lobe Sciences Ltd last traded?
The last trade of Lobe Sciences Ltd was at 06/05/26 12:45 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap